Results 211 to 220 of about 315,827 (302)

Powering Neurology Drug Development Trials to Reduce False Negative Results

open access: yesClinical and Translational Science, Volume 19, Issue 9, September 2026.
ABSTRACT Sensitive and reliable measurement of therapeutic outcomes in neurology drug trials remains challenging. Clinical rating scales and their total scores are often considered the gold standard and used as primary efficacy endpoints in studies because of their acceptance by the clinical community and regulators.
Hiromasa Mori   +3 more
wiley   +1 more source

Early neurodevelopmental outcome in newborns with mild hypoxic‐ischaemic encephalopathy

open access: yesDevelopmental Medicine &Child Neurology, Volume 68, Issue 9, Page 1261-1268, September 2026.
Abstract Aim To describe the natural history of newborn children with mild hypoxic‐ischaemic encephalopathy in the first year of life. Method This was a multicentre, prospective observational study involving five neonatal intensive care units in an Italian region using both structured clinical and neurophysiological assessments according to the Italian
Domenico M. Romeo   +16 more
wiley   +1 more source

Music processing in behavioural variant frontotemporal dementia and Alzheimer's disease: a functional MRI study. [PDF]

open access: yesBrain Commun
van 't Hooft JJ   +7 more
europepmc   +1 more source

Protein Biomarkers in Risk and Prognosis of Amyotrophic Lateral Sclerosis

open access: yesEuropean Journal of Neurology, Volume 33, Issue 9, September 2026.
ABSTRACT Background Plasma and cerebrospinal fluid (CSF) protein biomarkers in amyotrophic lateral sclerosis (ALS) may provide insight into disease mechanisms and yield clinically useful biomarkers. Methods Overall, 363 proteins in plasma and CSF from 198 patients with ALS and 125 matched controls were profiled using Olink assays.
Lu Pan   +23 more
wiley   +1 more source

Eating behaviour profiles across the frontotemporal dementia spectrum. [PDF]

open access: yesJ Neuropsychol
Sato Y   +11 more
europepmc   +1 more source

TUBA4A Pathogenic Variant Manifesting With Adulthood‐Onset Genetic Myasthenic Syndrome, Myopathy, and Infertility

open access: yesEuropean Journal of Neurology, Volume 33, Issue 9, September 2026.
ABSTRACT Objectives TUBA4A pathogenic variants are associated with ALS, frontotemporal dementia, spastic ataxia, spasticity, ataxia, Parkinson's disease, female infertility, macrothrombocytopenia, and myopathy. Four recently reported patients with TUBA4A neonatal/childhood onset myopathy had also a decrement on repetitive nerve stimulation (RNS), but ...
Margherita Milone   +7 more
wiley   +1 more source

Factors influencing accelerated progression in behavioral variant frontotemporal dementia. [PDF]

open access: yesJ Neurol
Split M   +49 more
europepmc   +1 more source

Future Prospects of Ultrasound: Role of Low‐Intensity Transcranial Ultrasound Stimulation in the Treatment of Neurological and Psychiatric Disorders

open access: yesEuropean Journal of Neurology, Volume 33, Issue 9, September 2026.
ABSTRACT Background Neurological and psychiatric disorders pose a persistent global health burden, with conventional therapies often providing inadequate relief. Transcranial ultrasound stimulation (TUS) has attracted considerable attention as a non‐invasive neuromodulation technique offering high spatial resolution and the distinctive capacity to ...
Yunjie Sui   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy